Below are some of the studies that the NRS Neuroprogressive Disease and Dementia Network have been involved in
CHIEF-PD
The UK’s largest study using cholinesterase inhibitors to reduce falls in Parkinson’s patients.
Exenatide-PD3
Investigating Exenatide’s potential disease-modifying effects in Parkinson’s Disease.
INSIGHT
Measuring insight into memory and thinking abilities in people with dementia.
PD-COMM
The UK’s largest study investigating Speech and Language therapy for Parkinson’s.
